Delhi High Court expressed anguish over the way things have transpired in the 2nd wave of COVID-19 where vaccine shortage is hitting everyone even when the Centre says the best way to fight the pandemic is to vaccinate everyone.
The high court, which was dealing with the issue of Sputnik V vaccine, also said going by the rule book to save human lives in these extraordinary times may be in jeopardy and “one has to look at the bigger picture".
The high court directed the Centre to release arbitral award of over ₹14 crore along with interest from 2012 to Panacea Biotec for manufacturing Sputnik V vaccine in India.
The high court was deliberating with the issue related to manufacturing of COVID vaccine Sputnik V by India s Panacea Biotec in collaboration with Russian Direct Investment Fund (RDIF).